nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A1—Dacarbazine—sarcoma	0.205	0.283	CbGbCtD
Dexmedetomidine—CYP2E1—Dacarbazine—sarcoma	0.158	0.218	CbGbCtD
Dexmedetomidine—CYP2E1—Mitoxantrone—sarcoma	0.123	0.169	CbGbCtD
Dexmedetomidine—CYP1A2—Dacarbazine—sarcoma	0.0916	0.126	CbGbCtD
Dexmedetomidine—CYP2E1—Etoposide—sarcoma	0.0775	0.107	CbGbCtD
Dexmedetomidine—CYP1A2—Etoposide—sarcoma	0.0448	0.0618	CbGbCtD
Dexmedetomidine—CYP2D6—Doxorubicin—sarcoma	0.0252	0.0347	CbGbCtD
Dexmedetomidine—Haemorrhage—Mitoxantrone—sarcoma	0.000854	0.00312	CcSEcCtD
Dexmedetomidine—Delirium—Doxorubicin—sarcoma	0.000853	0.00311	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Doxorubicin—sarcoma	0.000835	0.00305	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Epirubicin—sarcoma	0.000818	0.00298	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Vincristine—sarcoma	0.000814	0.00297	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000807	0.00294	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Doxorubicin—sarcoma	0.000802	0.00292	CcSEcCtD
Dexmedetomidine—Oliguria—Doxorubicin—sarcoma	0.000796	0.0029	CcSEcCtD
Dexmedetomidine—Pneumonia—Etoposide—sarcoma	0.000796	0.0029	CcSEcCtD
Dexmedetomidine—Anaemia—Thiotepa—sarcoma	0.000796	0.0029	CcSEcCtD
Dexmedetomidine—Angiopathy—Vincristine—sarcoma	0.000796	0.0029	CcSEcCtD
Dexmedetomidine—Ventricular tachycardia—Epirubicin—sarcoma	0.000793	0.00289	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Epirubicin—sarcoma	0.000793	0.00289	CcSEcCtD
Dexmedetomidine—Agitation—Thiotepa—sarcoma	0.000791	0.00289	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Vincristine—sarcoma	0.000791	0.00288	CcSEcCtD
Dexmedetomidine—Anaemia—Dactinomycin—sarcoma	0.00079	0.00288	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Etoposide—sarcoma	0.00078	0.00285	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Epirubicin—sarcoma	0.000779	0.00284	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Etoposide—sarcoma	0.000776	0.00283	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Etoposide—sarcoma	0.000776	0.00283	CcSEcCtD
Dexmedetomidine—Mental disorder—Vincristine—sarcoma	0.000769	0.0028	CcSEcCtD
Dexmedetomidine—Chills—Mitoxantrone—sarcoma	0.000767	0.0028	CcSEcCtD
Dexmedetomidine—Arrhythmia—Mitoxantrone—sarcoma	0.000763	0.00278	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Doxorubicin—sarcoma	0.000757	0.00276	CcSEcCtD
Dexmedetomidine—Fluid retention—Epirubicin—sarcoma	0.000753	0.00275	CcSEcCtD
Dexmedetomidine—Blood urea increased—Epirubicin—sarcoma	0.000749	0.00273	CcSEcCtD
Dexmedetomidine—Convulsion—Thiotepa—sarcoma	0.000746	0.00272	CcSEcCtD
Dexmedetomidine—Hypertension—Thiotepa—sarcoma	0.000744	0.00271	CcSEcCtD
Dexmedetomidine—Ventricular tachycardia—Doxorubicin—sarcoma	0.000734	0.00268	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.000734	0.00268	CcSEcCtD
Dexmedetomidine—Anxiety—Thiotepa—sarcoma	0.000731	0.00266	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Doxorubicin—sarcoma	0.000721	0.00263	CcSEcCtD
Dexmedetomidine—Confusional state—Thiotepa—sarcoma	0.000709	0.00258	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Epirubicin—sarcoma	0.000706	0.00257	CcSEcCtD
Dexmedetomidine—Anaemia—Vincristine—sarcoma	0.000706	0.00257	CcSEcCtD
Dexmedetomidine—Agitation—Vincristine—sarcoma	0.000702	0.00256	CcSEcCtD
Dexmedetomidine—Infection—Thiotepa—sarcoma	0.000698	0.00255	CcSEcCtD
Dexmedetomidine—Fluid retention—Doxorubicin—sarcoma	0.000697	0.00254	CcSEcCtD
Dexmedetomidine—Infection—Dactinomycin—sarcoma	0.000693	0.00253	CcSEcCtD
Dexmedetomidine—Blood urea increased—Doxorubicin—sarcoma	0.000693	0.00253	CcSEcCtD
Dexmedetomidine—Abnormal vision—Epirubicin—sarcoma	0.000692	0.00252	CcSEcCtD
Dexmedetomidine—Sepsis—Epirubicin—sarcoma	0.000688	0.00251	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Thiotepa—sarcoma	0.000688	0.00251	CcSEcCtD
Dexmedetomidine—Anaemia—Mitoxantrone—sarcoma	0.000687	0.00251	CcSEcCtD
Dexmedetomidine—Tachycardia—Thiotepa—sarcoma	0.000686	0.0025	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dactinomycin—sarcoma	0.000683	0.00249	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000662	0.00241	CcSEcCtD
Dexmedetomidine—Convulsion—Vincristine—sarcoma	0.000662	0.00241	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Etoposide—sarcoma	0.00066	0.0024	CcSEcCtD
Dexmedetomidine—Hypertension—Vincristine—sarcoma	0.000659	0.0024	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Epirubicin—sarcoma	0.000659	0.0024	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Doxorubicin—sarcoma	0.000653	0.00238	CcSEcCtD
Dexmedetomidine—Angiopathy—Etoposide—sarcoma	0.000645	0.00235	CcSEcCtD
Dexmedetomidine—Convulsion—Mitoxantrone—sarcoma	0.000644	0.00235	CcSEcCtD
Dexmedetomidine—Hypertension—Mitoxantrone—sarcoma	0.000642	0.00234	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Etoposide—sarcoma	0.00064	0.00234	CcSEcCtD
Dexmedetomidine—Abnormal vision—Doxorubicin—sarcoma	0.00064	0.00233	CcSEcCtD
Dexmedetomidine—Chills—Etoposide—sarcoma	0.000638	0.00232	CcSEcCtD
Dexmedetomidine—Sepsis—Doxorubicin—sarcoma	0.000637	0.00232	CcSEcCtD
Dexmedetomidine—Anxiety—Mitoxantrone—sarcoma	0.000631	0.0023	CcSEcCtD
Dexmedetomidine—Somnolence—Thiotepa—sarcoma	0.000625	0.00228	CcSEcCtD
Dexmedetomidine—Renal failure acute—Epirubicin—sarcoma	0.000624	0.00227	CcSEcCtD
Dexmedetomidine—Infection—Vincristine—sarcoma	0.000619	0.00226	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000613	0.00223	CcSEcCtD
Dexmedetomidine—Confusional state—Mitoxantrone—sarcoma	0.000612	0.00223	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Vincristine—sarcoma	0.00061	0.00223	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00061	0.00222	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000607	0.00221	CcSEcCtD
Dexmedetomidine—Infection—Mitoxantrone—sarcoma	0.000603	0.0022	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Vincristine—sarcoma	0.000602	0.0022	CcSEcCtD
Dexmedetomidine—Pain—Thiotepa—sarcoma	0.000601	0.00219	CcSEcCtD
Dexmedetomidine—Constipation—Thiotepa—sarcoma	0.000601	0.00219	CcSEcCtD
Dexmedetomidine—Pain—Dactinomycin—sarcoma	0.000597	0.00218	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000594	0.00217	CcSEcCtD
Dexmedetomidine—Tachycardia—Mitoxantrone—sarcoma	0.000592	0.00216	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Epirubicin—sarcoma	0.00059	0.00215	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000587	0.00214	CcSEcCtD
Dexmedetomidine—Hypotension—Vincristine—sarcoma	0.000582	0.00212	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Thiotepa—sarcoma	0.000579	0.00211	CcSEcCtD
Dexmedetomidine—Renal failure acute—Doxorubicin—sarcoma	0.000577	0.0021	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dactinomycin—sarcoma	0.000575	0.0021	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Thiotepa—sarcoma	0.000575	0.0021	CcSEcCtD
Dexmedetomidine—Anaemia—Etoposide—sarcoma	0.000572	0.00208	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00057	0.00208	CcSEcCtD
Dexmedetomidine—Hypotension—Mitoxantrone—sarcoma	0.000567	0.00207	CcSEcCtD
Dexmedetomidine—Abdominal pain—Thiotepa—sarcoma	0.000556	0.00203	CcSEcCtD
Dexmedetomidine—Body temperature increased—Thiotepa—sarcoma	0.000556	0.00203	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dactinomycin—sarcoma	0.000551	0.00201	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dactinomycin—sarcoma	0.000551	0.00201	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Epirubicin—sarcoma	0.000548	0.002	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Doxorubicin—sarcoma	0.000546	0.00199	CcSEcCtD
Dexmedetomidine—Dyspnoea—Mitoxantrone—sarcoma	0.000541	0.00197	CcSEcCtD
Dexmedetomidine—Somnolence—Mitoxantrone—sarcoma	0.00054	0.00197	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Vincristine—sarcoma	0.000538	0.00196	CcSEcCtD
Dexmedetomidine—Convulsion—Etoposide—sarcoma	0.000536	0.00195	CcSEcCtD
Dexmedetomidine—Hypertension—Etoposide—sarcoma	0.000534	0.00195	CcSEcCtD
Dexmedetomidine—Pain—Vincristine—sarcoma	0.000533	0.00194	CcSEcCtD
Dexmedetomidine—Constipation—Vincristine—sarcoma	0.000533	0.00194	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Epirubicin—sarcoma	0.000524	0.00191	CcSEcCtD
Dexmedetomidine—Pain—Mitoxantrone—sarcoma	0.000519	0.00189	CcSEcCtD
Dexmedetomidine—Constipation—Mitoxantrone—sarcoma	0.000519	0.00189	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000519	0.00189	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Vincristine—sarcoma	0.00051	0.00186	CcSEcCtD
Dexmedetomidine—Confusional state—Etoposide—sarcoma	0.000509	0.00186	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000508	0.00185	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Doxorubicin—sarcoma	0.000507	0.00185	CcSEcCtD
Dexmedetomidine—Infection—Etoposide—sarcoma	0.000502	0.00183	CcSEcCtD
Dexmedetomidine—Abdominal distension—Epirubicin—sarcoma	0.000501	0.00183	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Mitoxantrone—sarcoma	0.0005	0.00182	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000496	0.00181	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Etoposide—sarcoma	0.000494	0.0018	CcSEcCtD
Dexmedetomidine—Tachycardia—Etoposide—sarcoma	0.000493	0.0018	CcSEcCtD
Dexmedetomidine—Abdominal pain—Vincristine—sarcoma	0.000493	0.0018	CcSEcCtD
Dexmedetomidine—Body temperature increased—Vincristine—sarcoma	0.000493	0.0018	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Etoposide—sarcoma	0.000488	0.00178	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Doxorubicin—sarcoma	0.000485	0.00177	CcSEcCtD
Dexmedetomidine—Diarrhoea—Thiotepa—sarcoma	0.000481	0.00175	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mitoxantrone—sarcoma	0.00048	0.00175	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mitoxantrone—sarcoma	0.00048	0.00175	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00048	0.00175	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dactinomycin—sarcoma	0.000477	0.00174	CcSEcCtD
Dexmedetomidine—Hypotension—Etoposide—sarcoma	0.000472	0.00172	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00047	0.00171	CcSEcCtD
Dexmedetomidine—Dizziness—Thiotepa—sarcoma	0.000465	0.00169	CcSEcCtD
Dexmedetomidine—Abdominal distension—Doxorubicin—sarcoma	0.000464	0.00169	CcSEcCtD
Dexmedetomidine—Dyspnoea—Etoposide—sarcoma	0.00045	0.00164	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Epirubicin—sarcoma	0.000449	0.00164	CcSEcCtD
Dexmedetomidine—Somnolence—Etoposide—sarcoma	0.000449	0.00164	CcSEcCtD
Dexmedetomidine—Vomiting—Thiotepa—sarcoma	0.000447	0.00163	CcSEcCtD
Dexmedetomidine—Pneumonia—Epirubicin—sarcoma	0.000446	0.00163	CcSEcCtD
Dexmedetomidine—Vomiting—Dactinomycin—sarcoma	0.000444	0.00162	CcSEcCtD
Dexmedetomidine—Rash—Thiotepa—sarcoma	0.000443	0.00162	CcSEcCtD
Dexmedetomidine—Dermatitis—Thiotepa—sarcoma	0.000443	0.00161	CcSEcCtD
Dexmedetomidine—Headache—Thiotepa—sarcoma	0.00044	0.00161	CcSEcCtD
Dexmedetomidine—Rash—Dactinomycin—sarcoma	0.00044	0.0016	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Etoposide—sarcoma	0.000436	0.00159	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Epirubicin—sarcoma	0.000435	0.00159	CcSEcCtD
Dexmedetomidine—Pain—Etoposide—sarcoma	0.000432	0.00157	CcSEcCtD
Dexmedetomidine—Constipation—Etoposide—sarcoma	0.000432	0.00157	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Epirubicin—sarcoma	0.000431	0.00157	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vincristine—sarcoma	0.000426	0.00155	CcSEcCtD
Dexmedetomidine—Nausea—Thiotepa—sarcoma	0.000417	0.00152	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Etoposide—sarcoma	0.000416	0.00152	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Doxorubicin—sarcoma	0.000415	0.00151	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mitoxantrone—sarcoma	0.000415	0.00151	CcSEcCtD
Dexmedetomidine—Nausea—Dactinomycin—sarcoma	0.000414	0.00151	CcSEcCtD
Dexmedetomidine—Pneumonia—Doxorubicin—sarcoma	0.000413	0.00151	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Etoposide—sarcoma	0.000413	0.00151	CcSEcCtD
Dexmedetomidine—Dizziness—Vincristine—sarcoma	0.000412	0.0015	CcSEcCtD
Dexmedetomidine—Bradycardia—Epirubicin—sarcoma	0.000406	0.00148	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000402	0.00147	CcSEcCtD
Dexmedetomidine—Haemoglobin—Epirubicin—sarcoma	0.0004	0.00146	CcSEcCtD
Dexmedetomidine—Body temperature increased—Etoposide—sarcoma	0.000399	0.00146	CcSEcCtD
Dexmedetomidine—Abdominal pain—Etoposide—sarcoma	0.000399	0.00146	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Doxorubicin—sarcoma	0.000399	0.00146	CcSEcCtD
Dexmedetomidine—Haemorrhage—Epirubicin—sarcoma	0.000398	0.00145	CcSEcCtD
Dexmedetomidine—Vomiting—Vincristine—sarcoma	0.000396	0.00144	CcSEcCtD
Dexmedetomidine—Rash—Vincristine—sarcoma	0.000393	0.00143	CcSEcCtD
Dexmedetomidine—Dermatitis—Vincristine—sarcoma	0.000393	0.00143	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Epirubicin—sarcoma	0.000392	0.00143	CcSEcCtD
Dexmedetomidine—Headache—Vincristine—sarcoma	0.00039	0.00142	CcSEcCtD
Dexmedetomidine—Vomiting—Mitoxantrone—sarcoma	0.000386	0.00141	CcSEcCtD
Dexmedetomidine—Visual impairment—Epirubicin—sarcoma	0.000384	0.0014	CcSEcCtD
Dexmedetomidine—Rash—Mitoxantrone—sarcoma	0.000383	0.0014	CcSEcCtD
Dexmedetomidine—Dermatitis—Mitoxantrone—sarcoma	0.000382	0.00139	CcSEcCtD
Dexmedetomidine—Headache—Mitoxantrone—sarcoma	0.00038	0.00139	CcSEcCtD
Dexmedetomidine—Bradycardia—Doxorubicin—sarcoma	0.000375	0.00137	CcSEcCtD
Dexmedetomidine—Haemoglobin—Doxorubicin—sarcoma	0.00037	0.00135	CcSEcCtD
Dexmedetomidine—Nausea—Vincristine—sarcoma	0.00037	0.00135	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Epirubicin—sarcoma	0.00037	0.00135	CcSEcCtD
Dexmedetomidine—Haemorrhage—Doxorubicin—sarcoma	0.000369	0.00134	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Doxorubicin—sarcoma	0.000363	0.00132	CcSEcCtD
Dexmedetomidine—Angiopathy—Epirubicin—sarcoma	0.000361	0.00132	CcSEcCtD
Dexmedetomidine—Nausea—Mitoxantrone—sarcoma	0.000361	0.00131	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Epirubicin—sarcoma	0.000359	0.00131	CcSEcCtD
Dexmedetomidine—Chills—Epirubicin—sarcoma	0.000357	0.0013	CcSEcCtD
Dexmedetomidine—Arrhythmia—Epirubicin—sarcoma	0.000356	0.0013	CcSEcCtD
Dexmedetomidine—Visual impairment—Doxorubicin—sarcoma	0.000355	0.0013	CcSEcCtD
Dexmedetomidine—Mental disorder—Epirubicin—sarcoma	0.000349	0.00127	CcSEcCtD
Dexmedetomidine—Malnutrition—Epirubicin—sarcoma	0.000347	0.00126	CcSEcCtD
Dexmedetomidine—Diarrhoea—Etoposide—sarcoma	0.000345	0.00126	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Doxorubicin—sarcoma	0.000342	0.00125	CcSEcCtD
Dexmedetomidine—Angiopathy—Doxorubicin—sarcoma	0.000334	0.00122	CcSEcCtD
Dexmedetomidine—Dizziness—Etoposide—sarcoma	0.000334	0.00122	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Doxorubicin—sarcoma	0.000332	0.00121	CcSEcCtD
Dexmedetomidine—Chills—Doxorubicin—sarcoma	0.000331	0.00121	CcSEcCtD
Dexmedetomidine—Arrhythmia—Doxorubicin—sarcoma	0.000329	0.0012	CcSEcCtD
Dexmedetomidine—Mental disorder—Doxorubicin—sarcoma	0.000323	0.00118	CcSEcCtD
Dexmedetomidine—Vomiting—Etoposide—sarcoma	0.000321	0.00117	CcSEcCtD
Dexmedetomidine—Malnutrition—Doxorubicin—sarcoma	0.000321	0.00117	CcSEcCtD
Dexmedetomidine—Anaemia—Epirubicin—sarcoma	0.00032	0.00117	CcSEcCtD
Dexmedetomidine—Agitation—Epirubicin—sarcoma	0.000319	0.00116	CcSEcCtD
Dexmedetomidine—Rash—Etoposide—sarcoma	0.000318	0.00116	CcSEcCtD
Dexmedetomidine—Dermatitis—Etoposide—sarcoma	0.000318	0.00116	CcSEcCtD
Dexmedetomidine—Headache—Etoposide—sarcoma	0.000316	0.00115	CcSEcCtD
Dexmedetomidine—Convulsion—Epirubicin—sarcoma	0.0003	0.0011	CcSEcCtD
Dexmedetomidine—Nausea—Etoposide—sarcoma	0.0003	0.00109	CcSEcCtD
Dexmedetomidine—Hypertension—Epirubicin—sarcoma	0.000299	0.00109	CcSEcCtD
Dexmedetomidine—Anaemia—Doxorubicin—sarcoma	0.000297	0.00108	CcSEcCtD
Dexmedetomidine—Agitation—Doxorubicin—sarcoma	0.000295	0.00108	CcSEcCtD
Dexmedetomidine—Anxiety—Epirubicin—sarcoma	0.000294	0.00107	CcSEcCtD
Dexmedetomidine—Dry mouth—Epirubicin—sarcoma	0.000289	0.00105	CcSEcCtD
Dexmedetomidine—Confusional state—Epirubicin—sarcoma	0.000285	0.00104	CcSEcCtD
Dexmedetomidine—Infection—Epirubicin—sarcoma	0.000281	0.00103	CcSEcCtD
Dexmedetomidine—Convulsion—Doxorubicin—sarcoma	0.000278	0.00101	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Epirubicin—sarcoma	0.000277	0.00101	CcSEcCtD
Dexmedetomidine—Hypertension—Doxorubicin—sarcoma	0.000277	0.00101	CcSEcCtD
Dexmedetomidine—Tachycardia—Epirubicin—sarcoma	0.000276	0.00101	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Epirubicin—sarcoma	0.000274	0.000998	CcSEcCtD
Dexmedetomidine—Anxiety—Doxorubicin—sarcoma	0.000272	0.000993	CcSEcCtD
Dexmedetomidine—Dry mouth—Doxorubicin—sarcoma	0.000267	0.000974	CcSEcCtD
Dexmedetomidine—Hypotension—Epirubicin—sarcoma	0.000264	0.000964	CcSEcCtD
Dexmedetomidine—Confusional state—Doxorubicin—sarcoma	0.000264	0.000963	CcSEcCtD
Dexmedetomidine—Infection—Doxorubicin—sarcoma	0.00026	0.000949	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Doxorubicin—sarcoma	0.000256	0.000935	CcSEcCtD
Dexmedetomidine—Tachycardia—Doxorubicin—sarcoma	0.000256	0.000932	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Doxorubicin—sarcoma	0.000253	0.000923	CcSEcCtD
Dexmedetomidine—Dyspnoea—Epirubicin—sarcoma	0.000252	0.00092	CcSEcCtD
Dexmedetomidine—Somnolence—Epirubicin—sarcoma	0.000252	0.000917	CcSEcCtD
Dexmedetomidine—Hypotension—Doxorubicin—sarcoma	0.000245	0.000892	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000244	0.000891	CcSEcCtD
Dexmedetomidine—Pain—Epirubicin—sarcoma	0.000242	0.000882	CcSEcCtD
Dexmedetomidine—Constipation—Epirubicin—sarcoma	0.000242	0.000882	CcSEcCtD
Dexmedetomidine—Dyspnoea—Doxorubicin—sarcoma	0.000233	0.000851	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Epirubicin—sarcoma	0.000233	0.00085	CcSEcCtD
Dexmedetomidine—Somnolence—Doxorubicin—sarcoma	0.000233	0.000849	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Epirubicin—sarcoma	0.000231	0.000844	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000226	0.000824	CcSEcCtD
Dexmedetomidine—Constipation—Doxorubicin—sarcoma	0.000224	0.000816	CcSEcCtD
Dexmedetomidine—Pain—Doxorubicin—sarcoma	0.000224	0.000816	CcSEcCtD
Dexmedetomidine—Body temperature increased—Epirubicin—sarcoma	0.000224	0.000816	CcSEcCtD
Dexmedetomidine—Abdominal pain—Epirubicin—sarcoma	0.000224	0.000816	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Doxorubicin—sarcoma	0.000216	0.000787	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000214	0.000781	CcSEcCtD
Dexmedetomidine—Abdominal pain—Doxorubicin—sarcoma	0.000207	0.000755	CcSEcCtD
Dexmedetomidine—Body temperature increased—Doxorubicin—sarcoma	0.000207	0.000755	CcSEcCtD
Dexmedetomidine—Diarrhoea—Epirubicin—sarcoma	0.000194	0.000706	CcSEcCtD
Dexmedetomidine—Dizziness—Epirubicin—sarcoma	0.000187	0.000682	CcSEcCtD
Dexmedetomidine—Vomiting—Epirubicin—sarcoma	0.00018	0.000656	CcSEcCtD
Dexmedetomidine—Diarrhoea—Doxorubicin—sarcoma	0.000179	0.000653	CcSEcCtD
Dexmedetomidine—Rash—Epirubicin—sarcoma	0.000178	0.000651	CcSEcCtD
Dexmedetomidine—Dermatitis—Epirubicin—sarcoma	0.000178	0.00065	CcSEcCtD
Dexmedetomidine—Headache—Epirubicin—sarcoma	0.000177	0.000646	CcSEcCtD
Dexmedetomidine—Dizziness—Doxorubicin—sarcoma	0.000173	0.000631	CcSEcCtD
Dexmedetomidine—Nausea—Epirubicin—sarcoma	0.000168	0.000613	CcSEcCtD
Dexmedetomidine—Vomiting—Doxorubicin—sarcoma	0.000166	0.000607	CcSEcCtD
Dexmedetomidine—Rash—Doxorubicin—sarcoma	0.000165	0.000602	CcSEcCtD
Dexmedetomidine—Dermatitis—Doxorubicin—sarcoma	0.000165	0.000601	CcSEcCtD
Dexmedetomidine—Headache—Doxorubicin—sarcoma	0.000164	0.000598	CcSEcCtD
Dexmedetomidine—Nausea—Doxorubicin—sarcoma	0.000156	0.000567	CcSEcCtD
